Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Leaderboard Analytics
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
GLAXOSMITHKLINE LLC v. BOEHRINGER INGELHEIM PHARMACEUTICALS, INC.
Case Number:
2:19-cv-05321
Court:
Nature of Suit:
Other Statutes: Other Statutory Actions
Judge:
Firms
Companies
Sectors & Industries:
-
September 03, 2020
Boehringer Blocked From Making False GSK Inhaler Claims
A Pennsylvania federal judge on Thursday issued a preliminary injunction blocking Boehringer Ingelheim Pharmaceuticals from conveying in training materials for its sales representatives false or misleading information about rival GlaxoSmithKline LLC's inhalers for patients with chronic obstructive pulmonary disease.
-
November 13, 2019
GSK Says Boehringer Spreading Lies About Its Inhalers
Pharmaceutical company GlaxoSmithKline LLC on Tuesday accused rival Boehringer Ingelheim Pharmaceuticals Inc. of spreading false and misleading information about GSK inhalers for patients with chronic obstructive pulmonary disease, according to a suit filed in Pennsylvania federal court.